Australia has ‘conquered’ the AstraZeneca vax clot threat: Here’s how
Haematologists were on a learning curve, but now diagnosis and treatment protocols are saving lives
Mortality from thrombosis and thrombocytopenia syndrome linked to AstraZeneca’s COVID-19 vaccine is far lower in Australia than the 25% originally touted, a leading haematologist says.
The latest figures from the TGA show 27 confirmed and six probable cases of the syndrome and include only one death.
